Shreedhar Vijay 4
4 · Adamas Pharmaceuticals Inc · Filed Jun 23, 2021
Insider Transaction Report
Form 4
Shreedhar Vijay
Chief Commercial Officer
Transactions
- Sale
Common Stock
2021-06-21$5.16/sh−6,200$31,983→ 165,735 total
Footnotes (3)
- [F1]Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The shares were sold at prices ranging from $5.10 to $5.20. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes 2,500 shares acquired under the issuer's employee stock purchase plan on May 28, 2021.